Tagged with Pharm

Greece In terms of value, global giants Pfizer, Novartis and Sanofi lead the way in Greece. Click here to see more facts and figures from Greece

Greece Greece Fact Sheet In comparison to other countries heavily affected by the Eurozone debt crisis, Greece is still struggling to find its feet. Greece fares poorly on almost all macroeconomic indicators compared to the Euro area since the start of the recession. The Greek pharma market has shrunk in value significantly from…

Taiwan C.Y. Cheng, chairman and president of Formosa Laboratories, shares exciting news about the establishment of a new drug development company, Formosa Pharmaceuticals. He explains how the know-how gained from running a successful international API production business will help Formosa avoid the typical mistakes that young R&D companies face. Mr. Cheng,…

Taiwan With 7,000 employees in 25 locations across 12 countries in the region, PAREXEL now has more than a third of its global staff in Asia Pacific (APAC). Albert Liou, Vice Chairman, Asia Pacific, PAREXEL, discusses the biotech momentum that has been boosting the attractiveness of the region in terms of…

Switzerland The southern Swiss canton of Ticino does not have the life science reputation of Basel, Zurich or Geneva, but benefits from an open business environment, strategic location, and a thriving network of pharmaceutical SMEs. “Ticino is really a perfect example of the excellence of Swiss SMEs in the pharma industry, as…

Taiwan Peter Tsai, founder, CEO, and chairman of Orient EuroPharma (OEP), one of the leading groups of healthcare companies in Taiwan, provides insights into his strategic vision to double the group’s revenues within the next five years and nurture the long-term growth of the company he founded in 1982, while OEP’s…

Taiwan Peter Tsai, founder, CEO, and chairman of Orient EuroPharma (OEP), one of the leading groups of healthcare companies in Taiwan, provides insights into his strategic vision to double the group’s revenues within the next five years and nurture the long-term growth of the company he founded in 1982, while OEP’s…

Indonesia Alban Nérot, managing director at Servier Indonesia, explains the transformational change of the Indonesian affiliate to ensure the sustainable growth of its business in the country as well as the importance of medical education to show to doctors and other healthcare professionals the benefits of innovative medicine. Mr. Nérot, you…

Taiwan In an exclusive interview, Amy Huang, general manager of OBI Pharma, shares her plans to bolster the international development of the company and further strengthen its expertise throughout the drug development process. She also elaborates on the key next steps that lie ahead for OBI Pharma’s flagship immuno-oncology therapy, Adagloxad…

Taiwan Leveraging Taiwan’s remarkable talent pool in chemistry, some of the country’s fastest-growing companies have been concentrating their efforts on technology platforms that allow them to develop a plethora of potentially game-changing products, rather than focusing all their resources on the risky development of a single, potentially groundbreaking product.   Taiwan…

Mexico Spearheading one of the most trusted and recognizable pharmacy chain brands in the country, Isaac Valdivieso, Director General of Farmacia San Pablo, shares his insights about the company’s stance in the market. He speaks about building an efficient corporate strategy, the customer-centric approach that sets them apart from the competition,…

Mexico Ricardo Spínola, CEO at Farmapiel, explains his clear vision for the company and showcases the added value of Farmapiel’s product offering for both patients and healthcare professionals. Mr. Spínola you have more than 16 years of experience in top management positions for leading pharmaceutical companies and private hospitals. Nevertheless, in…